Lucid Genomics Announces Compatibility Partnership with Oxford Nanopore Technologies
Lucid Genomics’ tertiary pipeline is validated for the interpretation of data generated using Oxford Nanopore sequencing.
Lucid Genomics’ tertiary pipeline is validated for the interpretation of data generated using Oxford Nanopore sequencing.
Strategic Initiative Strengthens Berlin as Europe’s Hub of Digital Cardiology
Charité study collates global therapeutic experiences for the first time
Groundbreaking discovery of antimicrobial peptides in ant venom has far-reaching implications
In “Nature Communications,” Max Delbrück Center researchers show how immune cells initiate zebrafish heart regeneration, highlighting the possibility that precisely timed inflammatory signaling of specific immune cells — rather than broad…
On April, 22th, the BeCAT and Si-M were inaugurated in Berlin—two important beacons for our region. What they share is the goal of developing effective personalized therapies for diseases that have so far been considered incurable.
16.-20.11.2026 | Anmeldeschluss 30.06.2026
New study presents theoretical framework to address a conceptual gap in our understanding of ADHD
According to a TU Berlin study, ChatGPT models tend to make overly cautious recommendations, and are currently inadequate for the targeted management of patients in healthcare systems
On the occasion of German Biotech Days (DBT) 2026 in Leipzig, the Working Group of the German BioRegions once again presented its renowned Innovation Award on 21 April 2026. For the past 19 years, the award has honored innovative biotechnological…